Integra LifeSciences Holdings Corp. has completed the sale of its Extremity Orthopedics business to Smith+Nephew, it announced this week.
The Princeton-based medical technology company said the $240 million deal, which was first announced in September, will help it focus its portfolio.
“With this divestiture, we will now be in an even stronger position to capitalize on our core products and technologies in neurosurgery and regenerative medicine, and provide greater value to our customers and shareholders,” CEO and President Peter Arduini said in a prepared statement.
For Integra, Piper Sandler & Co. served as financial adviser and Morgan, Lewis & Bockius LLP served as legal adviser.
